In the hypermutated tumors, ARID1A, RNF43, LRP1B, FAT1 ̃4, MLL1 ̃4 and MACF1 were frequent targets of mutation in both CRC and STAD. This evidence concerns the gene FAT1 and gastric adenocarcinoma.